Join Growin Stock Community!

Summit therapeutics inc(SMMT.US Overview)

US StockHealthcare
No presentation for SMMT

SMMT AI Insights

SMMT Overall Performance

SMMT AI Analysis & Strategy

SMMT Recent Performance

-16.47%

Summit therapeutics inc

-0.68%

Avg of Sector

-1.92%

S&P 500

SMMT PowerScanner

SMMT Key Information

SMMT Valuation Metrics

SMMT Earnings Table

SMMT Profile

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.

Price of SMMT

SMMT FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer